Search results
AbbVie Inc. (NYSE:ABBV) Shares Bought by Pathway Financial Advisors LLC
ETF DAILY NEWS· 7 hours agoPathway Financial Advisors LLC raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.7% in the 1st quarter, according to its most recent filing with the SEC. The ...
American National Bank Acquires 1,816 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 hours agoAmerican National Bank grew its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% during the first quarter, according to its most recent filing with the ...
JD Supra: AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands...
JD Supra· 4 hours agoOn May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been entrusted to the ...
AbbVie Inc. (NYSE:ABBV) Stock Holdings Boosted by Inscription Capital LLC
ETF DAILY NEWS· 7 hours agoInscription Capital LLC raised its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 20.9% in the first quarter, according to the company in its most recent 13F ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Cox Capital Mgt LLC
ETF DAILY NEWS· 9 hours agoCox Capital Mgt LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.3% during the 1st quarter, HoldingsChannel reports. The institutional investor ...
Legacy Financial Strategies LLC Acquires 620 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 hours agoLegacy Financial Strategies LLC grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.8% in the 1st quarter, according to its most recent disclosure with the Securities ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 4 days agoThe latest trading session saw AbbVie (ABBV) ending at $171.36, denoting a +0.99% adjustment from...
AbbVie names Roxanne Austin as new lead independent director By Investing.com
Investing.com· 2 days agoAustin will be taking over from Glenn F. Tilton, who will continue his tenure on the board as an...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 3 days agoAbbVie ABBV announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga ...